Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs Medline Inc. Class A Common Stock (MDLN) Price & Performance

CVS Health CorpTrade
Medline Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs Medline Inc. Class A Common Stock — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.29B), while Medline Inc. Class A Common Stock trades at $35.74 (market cap $31.36B). The key difference: CVS Health Corp is far larger — about 3.6× Medline Inc. Class A Common Stock's market cap, and CVS Health Corp pays a 3.03% dividend while Medline Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Medline Inc. Class A Common Stock for 0 Days on average.

CVSMDLN
Market Cap
$112.29B$31.36B
Volume
7,763,67610,191,251
Sector
HealthHealth
52-Week High
$110.60$49.99
52-Week Low
$70.08$31.64
Typical Hold Time
83 Days0 Days
Enterprise Value
$174.64B$41.32B
Dividend Yield
3.03%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.

The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.

Medline Inc. Class A Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVS

No sentiment data available yet.

MDLN
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS →

About Medline Inc. Class A Common Stock

Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.

Read more on MDLN →